AI-Based Pharmaceutical R&D Services Market on a High-Growth Trajectory – report by Towards Healthcare

▤ Summary

The report says the AI-based pharmaceutical R&D services market is growing quickly as drug developers adopt AI to speed discovery and cut R&D costs. It highlights strong demand for SaaS and cloud-based access, especially among pharmaceutical companies, large biotechs, and CROs. The report also points to generative AI, virtual screening, and biologics-focused applications as major growth areas. North America leads the market today, while Asia-Pacific is expected to grow the fastest over the forecast period. The article also notes regulation, data governance, and explainability as key barriers to broader adoption.

▦ Linked Companies